These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. LDS-25 as a discriminative stimulus for response selection by pigeons. Järbe TU Pharmacol Biochem Behav; 1980 Oct; 13(4):549-54. PubMed ID: 6107936 [TBL] [Abstract][Full Text] [Related]
29. Differences in the stimulus properties of barbital and hallucinogens. Hirschhorn ID; Winter JC Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438 [TBL] [Abstract][Full Text] [Related]
30. Training dose as a factor in LSD-saline discrimination. White FJ; Appel JB Psychopharmacology (Berl); 1982; 76(1):20-5. PubMed ID: 6805003 [TBL] [Abstract][Full Text] [Related]
31. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. White FJ; Appel JB Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800 [TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus properties of lysergic acid diethylamide in the monkey. Nielsen EB J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503 [TBL] [Abstract][Full Text] [Related]
33. Effects of quipazine on behavior under a multiple schedule of reinforcement. Poling A; Appel JB Pharmacol Biochem Behav; 1978 Apr; 8(4):491-2. PubMed ID: 674254 [TBL] [Abstract][Full Text] [Related]
34. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304 [TBL] [Abstract][Full Text] [Related]
35. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives. Fiorella D; Rabin RA; Winter JC Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618 [TBL] [Abstract][Full Text] [Related]
36. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists. Grome JJ; Harper AM J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273 [TBL] [Abstract][Full Text] [Related]
37. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Winter JC; Eckler JR; Rabin RA Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016 [TBL] [Abstract][Full Text] [Related]
38. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Marona-Lewicka D; Thisted RA; Nichols DE Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230 [TBL] [Abstract][Full Text] [Related]
39. Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics. Hirschhorn ID; Rosecrans JA Psychopharmacology (Berl); 1976 May; 47(1):65-9. PubMed ID: 8812 [TBL] [Abstract][Full Text] [Related]
40. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats. Beninger RJ Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]